| |
|
|
|
| |
|
|
  | | |
17-beta hydroxysteroid dehydrogenase 3 deficiency
|
HSD17B3*
|
Hsd17b3*
|
1 model
|
Alliance of Genome Resources
|
|
46,XY sex reversal
|
DHH*
|
Dhh*
|
1 model
|
Alliance of Genome Resources
|
|
androgen insensitivity syndrome
|
AR*
|
Ar*
|
8 models
|
Alliance of Genome Resources
|
|
cryptorchidism
|
INSL3*
|
Insl3*
|
5 models
|
Alliance of Genome Resources
|
|
persistent Mullerian duct syndrome
|
AMHR2*
|
Amhr2*
|
1 model
|
Alliance of Genome Resources
|
| | | |
46 XX gonadal dysgenesis
|
FANCL
|
Fancl*
|
1 model
|
Alliance of Genome Resources
|
|
androgen insensitivity syndrome
|
FKBP4
|
Fkbp4*
|
2 models
|
Alliance of Genome Resources
|
|
hyperandrogenism
|
|
Prl3c1*
|
1 model
|
|
| | | |
46 XX gonadal dysgenesis
|
SPIDR*
|
Spidr
|
|
Alliance of Genome Resources
|
|
46 XX gonadal dysgenesis
|
ZSWIM7*
|
Zswim7
|
|
Alliance of Genome Resources
|
|
46 XX gonadal dysgenesis
|
FSHR*
|
Fshr
|
|
Alliance of Genome Resources
|
|
46,XX sex reversal 1
|
SRY*
|
Sry
|
|
Alliance of Genome Resources
|
|
46,XX sex reversal 4
|
NR5A1*
|
Nr5a1
|
|
Alliance of Genome Resources
|
|
46,XX sex reversal 5
|
NR2F2*
|
Nr2f2
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal
|
DHX37*
|
Dhx37
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal
|
SRY*
|
Sry
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 1
|
SRY*
|
Sry
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 2
|
NR0B1*
|
Nr0b1
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 3
|
NR5A1*
|
Nr5a1
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 5
|
CBX2*
|
Cbx2
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 6
|
MAP3K1*
|
Map3k1
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 7
|
DHH*
|
Dhh
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 8
|
AKR1C2*,
AKR1C4*,
AKR1C1,
AKR1C3
|
Akr1c6,
Akr1c12,
Akr1c13,
Akr1c14,
Akr1c18,
Akr1c19,
Akr1c20,
Akr1c21,
Akr1cl
|
|
Alliance of Genome Resources
|
|
46,XY sex reversal 9
|
ZFPM2*
|
Zfpm2
|
|
Alliance of Genome Resources
|
|
cryptorchidism
|
HOXD13*
|
Hoxd13
|
|
Alliance of Genome Resources
|
|
cryptorchidism
|
RXFP2*
|
Rxfp2
|
2 models
|
Alliance of Genome Resources
|
|
cryptorchidism
|
AR*
|
Ar
|
1 model
|
Alliance of Genome Resources
|
|
disorder of sexual development
|
HSD17B3*
|
Hsd17b3
|
|
Alliance of Genome Resources
|
|
disorder of sexual development
|
AMH*
|
Amh
|
|
Alliance of Genome Resources
|
|
gonadal dysgenesis
|
TSPYL1*,
TSPYL6
|
Tspyl1
|
|
Alliance of Genome Resources
|
|
hyperandrogenism
|
IL6ST*
|
Il6st
|
|
Alliance of Genome Resources
|
|
Leydig cell hypoplasia
|
LHCGR*
|
Lhcgr
|
|
Alliance of Genome Resources
|
|
methemoglobinemia and ambiguous genitalia
|
CYB5A*
|
Cyb5a
|
|
Alliance of Genome Resources
|
|
Mullerian aplasia and hyperandrogenism
|
WNT4*
|
Wnt4
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 1
|
FSHR*
|
Fshr
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 2
|
BMP15*
|
Bmp15
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 3
|
PSMC3IP*
|
Psmc3ip
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 4
|
MCM9*
|
Mcm9
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 5
|
SOHLH1*
|
Sohlh1
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 6
|
NUP107*
|
Nup107
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 7
|
MRPS22*
|
Mrps22
|
|
Alliance of Genome Resources
|
|
ovarian dysgenesis 8
|
ESR2*
|
Esr2
|
|
Alliance of Genome Resources
|
|
partial androgen insensitivity syndrome
|
AR*
|
Ar
|
|
Alliance of Genome Resources
|
|
persistent Mullerian duct syndrome
|
AMH*
|
Amh
|
|
Alliance of Genome Resources
|
|
Turner syndrome
|
VDR*
|
Vdr
|
|
Alliance of Genome Resources
|
|
Turner syndrome
|
IGFBP3*
|
Igfbp3
|
|
Alliance of Genome Resources
|
Excel File